Abstract:The majority of depleting monoclonal antibody (mAb) drugs elicit responses via Fc-FcγR and Fc-C1q interactions. Optimal C1q interaction is achieved through hexameric Fc:Fc interactions at the target cell surface. Herein is described an approach to exploit the tailpiece of the naturally multimeric IgM to augment hexamerisation of IgG. Fusion of the C-terminal tailpiece of IgM promoted spontaneous hIgG hexamer formation, resulting in enhanced C1q recruitment and complement-dependent cytotoxicity (CDC) but with o… Show more
“…In a mutational screening approach, they identified two conserved glutamic acid residues in the Fc region of IgG — E345 and E430 — for which the substitution of any other amino acid enhanced IgG hexamer formation and complement activation for a wide range of cell surface targets. Sopp et al demonstrated that self-assembly dependent on target binding can also be facilitated by extending IgG1 antibodies with the µ-tailpiece mentioned above, but in which the carboxyl-terminal cysteine is mutated to a serine to prevent covalent hexamerization 171 . By systematically depleting individual complement components, Taylor et al showed that antibodies containing hexamer-enhancing mutations require a reduced presence of membrane attack complex-forming complement components to promote CDC compared to the non-mutated parent antibodies 172 .…”
Section: Avidity Engineering Of Antibody Therapeuticsmentioning
“…In a mutational screening approach, they identified two conserved glutamic acid residues in the Fc region of IgG — E345 and E430 — for which the substitution of any other amino acid enhanced IgG hexamer formation and complement activation for a wide range of cell surface targets. Sopp et al demonstrated that self-assembly dependent on target binding can also be facilitated by extending IgG1 antibodies with the µ-tailpiece mentioned above, but in which the carboxyl-terminal cysteine is mutated to a serine to prevent covalent hexamerization 171 . By systematically depleting individual complement components, Taylor et al showed that antibodies containing hexamer-enhancing mutations require a reduced presence of membrane attack complex-forming complement components to promote CDC compared to the non-mutated parent antibodies 172 .…”
Section: Avidity Engineering Of Antibody Therapeuticsmentioning
“…From the IgM perspective, the full-length or tailpiece IgM-Fc could be explored to achieve the avid effect demonstrated in other studies. [21] , [132] In this case, the IgM-Fc fusion may elicit humoral cytolytic reactions and pathogen agglutination (i.e., the formation of aggregated immune complexes) as reported for bacterial pathogens. [133] This agglutination effect results in a superior neutralization activity to IgA-Fc and IgG-Fc.…”
Section: Promising Bionanotechnology Approaches To Achieve Improved T...mentioning
“…Hexameric IgG via IgM tailpiece fusion or Fc-Fc interface mutations have been shown to increase CDC function, crosslinking ability of cell surface receptors or SARS-CoV-2 virus neutralization ability 14,15 . Our hexameric IgG-Fc structure provides detail information of the Fc-Fc interaction and guidance for further engineering for therapeutic application of IgG hexamer.…”
IgG exists mainly as monomer, but recent studies suggest that IgG forms hexamer to mediate antibody functions. Although many structures of IgG monomer and its fragments are determined, there is no IgG hexamer structure at atomic level due to the weak Fc-Fc interactions. Here we engineered a hexameric IgG with IgM tailpiece fusion and determined the structure by cryo-EM. IgG-Fc hexamer forms hexagon symmetry with the six Fcs lie in a plane with Fc-Fc interaction in a mutual lock-and-key mode. This structure provides structural insights into Fc-Fc interaction of IgG and reveals molecular basis for its function.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.